AlejandraCGurtmanMD

Physician

Dr. Gurtman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions.
Matthew Davis, William Towner, Elliot DeHaan, Qin Jiang, Wen Li
Clinical Infectious Diseases. 2024-11-11
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.
Edward E Walsh, Gonzalo Pérez Marc, Ann R Falsey, Qin Jiang, Daniel Eiras
The New England Journal of Medicine. 2024-10-17
1 citations
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.
Edward E Walsh, Ann R Falsey, Agnieszka M Zareba, Qin Jiang, Alejandra Gurtman
The Journal of Infectious Diseases. 2024-10-16

Journal Articles

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P Polack, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kenneth Koury, Robert W Frenck, Philip R Dormitzer, The New England Journal of Medicine

FDA Experts Recommend RSV Vaccines for Adults 60 and over. What's Next?February 28th, 2023
IDSA Honors 175 Distinguished Physicians, Scientists with FIDSA DesignationAugust 17th, 2022
Will a New Wave of RSV Vaccines Stop the Dangerous Virus?August 4th, 2022
Join now to see all

Mount Sinai-New York State - Argentina HIV Prevention PRFogarty International Center2001–2003
Mount Sinai-New York State-Argentina HIV PreventionFogarty International Center2000